On Thursday, Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH) reported fourth-quarter adjusted EPS of 92 cents, up from 88 cents a year ago, but missing the consensus of 94 cents. Amphastar is a ...

Amneal Pharmaceuticals (NYSE:NASDAQ:AMRX), a commercial-stage biopharmaceutical company with a market capitalization of $2.53 billion, has been positioning itself for a new phase of multi-year growth ...

As supply chain vulnerabilities intensify and competition accelerates, the cost of this underutilization could risk India's ...

WENZHOU, ZHEJIANG PROVINCE, CHINA, January 19, 2026 /EINPresswire.com/ -- As the global pharmaceutical and healthcare ...

In pharmaceutical manufacturing, software validation is innovation’s silent killer. A single user requirements specification (URS) takes weeks. Test plans stretch for months. Change controls bog down ...

In a report released yesterday, Alec Stranahan from Bank of America Securities reiterated a Buy rating on Agios Pharma (AGIO – Research Report), with a price target of $60.00. Pick the best stocks and ...

Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Jacobio Pharmaceuticals presented ...

In the first part of his Pharma Commerce video interview, Joe Hudicka, entrepreneur and supply chain expert, explains how pharma leaders can detect early warning signs beyond their own silos and adapt ...

Lucknow: UP offers some of the most competitive policies and incentives in the country for pharmaceutical investments, said industrial development, export promotion and investment minister Nand Gopal ...

Hudicka also comments on practical steps can supply chain leaders take to build trust in AI-driven ecosystems without ...